<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05612750</url>
  </required_header>
  <id_info>
    <org_study_id>IRB-65439</org_study_id>
    <nct_id>NCT05612750</nct_id>
  </id_info>
  <brief_title>Comparative Effectiveness of Online 8-session CBT vs. 1-Session Empowered Relief for Chronic Pain - The PROGRESS Study</brief_title>
  <acronym>PROGRESS</acronym>
  <official_title>Comparative Effectiveness of Online Cognitive Behavioral Therapy vs. An Online Single-Session Pain Relief Skills Class for Chronic Pain - The PROGRESS Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Patient-Centered Outcomes Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to conduct a pragmatic clinical trial comparing the&#xD;
      effectiveness of: (1) 8-week cognitive behavioral therapy for chronic pain (pain-CBT; sixteen&#xD;
      hours total treatment time); and (2) a 1-session pain relief skills intervention for chronic&#xD;
      pain (Empowered Relief; two hours total treatment time).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to conduct a pragmatic clinical trial comparing the&#xD;
      effectiveness: (1) 8-session cognitive behavioral therapy for chronic pain (pain-CBT); and&#xD;
      (2) a 1-session pain relief skills intervention for chronic pain (Empowered Relief). The&#xD;
      investigators aim to understand for patients which treatment works best.&#xD;
&#xD;
      Online evidence-based behavioral treatment for pain will greatly expand access to patients&#xD;
      across the U.S. living with diverse chronic pain conditions. Results from this study will&#xD;
      fill several critical gaps in evidence that are preventing patients and physicians from&#xD;
      making informed decisions about their pain care.&#xD;
&#xD;
      This study will provide a low-cost, relatively low-risk, widely available and feasible&#xD;
      protocol that directly addresses the needs of millions of community-based outpatients and&#xD;
      their physicians.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2023</start_date>
  <completion_date type="Anticipated">May 1, 2028</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2028</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>A pragmatic clinical trial randomizing to one of two (standard of care) online group behavioral treatments: (1) 8-session cognitive behavioral therapy for chronic pain (pain-CBT); and (2) single-session pain relief skills intervention for chronic pain (Empowered Relief).</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Care Provider)</masking>
    <masking_description>Participants and research staff will know arm assignment. Co-investigators, project statisticians, and the protocol director at each study site will remain blinded until final assessment.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Pain Intensity</measure>
    <time_frame>1 months</time_frame>
    <description>Compare study treatments for primary outcomes post-treatment with the Numeric Rating Scale (0-10)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain Intensity</measure>
    <time_frame>2 months</time_frame>
    <description>Compare study treatments for primary outcomes post-treatment with the Numeric Rating Scale (0-10)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain Intensity</measure>
    <time_frame>3 months</time_frame>
    <description>Compare study treatments for primary outcomes post-treatment with the Numeric Rating Scale (0-10)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain Intensity</measure>
    <time_frame>6 months</time_frame>
    <description>Compare study treatments for primary outcomes post-treatment with the Numeric Rating Scale (0-10)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain Interference</measure>
    <time_frame>1 month</time_frame>
    <description>Compare study treatments for primary outcomes post-treatment with the Numeric Rating Scale (0-10)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain Interference</measure>
    <time_frame>2 months</time_frame>
    <description>Compare study treatments for primary outcomes post-treatment with the PROMIS Pain Interference 6-item scale.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain Interference</measure>
    <time_frame>3 months</time_frame>
    <description>Compare study treatments for primary outcomes post-treatment with the PROMIS Pain Interference 6-item scale.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain Interference</measure>
    <time_frame>6 months</time_frame>
    <description>Compare study treatments for primary outcomes post-treatment with the PROMIS Pain Interference 6-item scale.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sleep Disturbance</measure>
    <time_frame>1 month</time_frame>
    <description>Compare treatment groups on the PROMIS Sleep Disturbance 6-item</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleep Disturbance</measure>
    <time_frame>2 months</time_frame>
    <description>Compare treatment groups on the PROMIS Sleep Disturbance 6-item</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleep Disturbance</measure>
    <time_frame>3 months</time_frame>
    <description>Compare treatment groups on the PROMIS Sleep Disturbance 6-item</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleep Disturbance</measure>
    <time_frame>6 months</time_frame>
    <description>Compare treatment groups on the PROMIS Sleep Disturbance 6-item</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Bothersomeness</measure>
    <time_frame>1 month</time_frame>
    <description>Compare treatment groups for Pain Bothersomeness on a Numeric Rating Scale (0-10)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Bothersomeness</measure>
    <time_frame>2 months</time_frame>
    <description>Compare treatment groups for Pain Bothersomeness on a Numeric Rating Scale (0-10)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Bothersomeness</measure>
    <time_frame>3 months</time_frame>
    <description>Compare treatment groups for Pain Bothersomeness on a Numeric Rating Scale (0-10)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Bothersomeness</measure>
    <time_frame>6 months</time_frame>
    <description>Compare treatment groups for Pain Bothersomeness on a Numeric Rating Scale (0-10)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Catastrophizing</measure>
    <time_frame>1 months</time_frame>
    <description>Pain Catastrophizing Scale is a 13-item measure with a total score ranging from 0-52 with higher scores indicative of more catastrophizing.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Catastrophizing</measure>
    <time_frame>2 months</time_frame>
    <description>Pain Catastrophizing Scale is a 13-item measure with a total score ranging from 0-52 with higher scores indicative of more catastrophizing.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Catastrophizing</measure>
    <time_frame>3 months</time_frame>
    <description>Pain Catastrophizing Scale is a 13-item measure with a total score ranging from 0-52 with higher scores indicative of more catastrophizing. We aim to obtain &gt;30% reduction in PCS scores after the intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Catastrophizing</measure>
    <time_frame>6 months</time_frame>
    <description>Pain Catastrophizing Scale is a 13-item measure with a total score ranging from 0-52 with higher scores indicative of more catastrophizing.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anxiety</measure>
    <time_frame>1 month</time_frame>
    <description>Compare treatment groups for anxiety using the PROMIS Anxiety 6-item</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anxiety</measure>
    <time_frame>2 months</time_frame>
    <description>Compare treatment groups for anxiety using the PROMIS Anxiety 6-item</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anxiety</measure>
    <time_frame>3 months</time_frame>
    <description>Compare treatment groups for anxiety using the PROMIS Anxiety 6-item</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anxiety</measure>
    <time_frame>6 months</time_frame>
    <description>Compare treatment groups for anxiety using the PROMIS Anxiety 6-item</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Satisfaction with Social Roles/Responsibilities</measure>
    <time_frame>1 month</time_frame>
    <description>Compare treatment groups for PROMIS 6 item Satisfaction with Social Roles/Responsibilities</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Satisfaction with Social Roles/Responsibilities</measure>
    <time_frame>2 months</time_frame>
    <description>Compare treatment groups for PROMIS 6 item Satisfaction with Social Roles/Responsibilities</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Satisfaction with Social Roles/Responsibilities</measure>
    <time_frame>3 months</time_frame>
    <description>Compare treatment groups for PROMIS 6 item Satisfaction with Social Roles/Responsibilities</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Satisfaction with Social Roles/Responsibilities</measure>
    <time_frame>6 months</time_frame>
    <description>Compare treatment groups for PROMIS 6 item Satisfaction with Social Roles/Responsibilities</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Global Impression of Change</measure>
    <time_frame>1months</time_frame>
    <description>Compare treatment groups for PROMISE 1 item Global Impression of Change scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Global Impression of Change</measure>
    <time_frame>2 month</time_frame>
    <description>Compare treatment groups for PROMISE 1 item Global Impression of Change scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Global Impression of Change</measure>
    <time_frame>3 months</time_frame>
    <description>Compare treatment groups for PROMISE 1 item Global Impression of Change scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Global Impression of Change</measure>
    <time_frame>6 months</time_frame>
    <description>Compare treatment groups for PROMISE 1 item Global Impression of Change scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depression</measure>
    <time_frame>1 month</time_frame>
    <description>Compare study treatments for primary outcomes post-treatment with the PROMIS 6 item Depression scale.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depression</measure>
    <time_frame>2 months</time_frame>
    <description>Compare study treatments for primary outcomes post-treatment with the PROMIS 6 item Depression scale.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depression</measure>
    <time_frame>3 months</time_frame>
    <description>Compare study treatments for primary outcomes post-treatment with the PROMIS 6 item Depression scale.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depression</measure>
    <time_frame>6 months</time_frame>
    <description>Compare study treatments for primary outcomes post-treatment with the PROMIS 6 item Depression scale.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fatigue</measure>
    <time_frame>1 month</time_frame>
    <description>Compare study treatments for primary outcomes post-treatment with the PROMIS 6 item Fatigue scale.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fatigue</measure>
    <time_frame>2 months</time_frame>
    <description>Compare study treatments for primary outcomes post-treatment with the PROMIS 6 item Fatigue scale.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fatigue</measure>
    <time_frame>3 months</time_frame>
    <description>Compare study treatments for primary outcomes post-treatment with the PROMIS 6 item Fatigue scale.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fatigue</measure>
    <time_frame>6 months</time_frame>
    <description>Compare study treatments for primary outcomes post-treatment with the PROMIS 6 item Fatigue scale.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anger</measure>
    <time_frame>1 month</time_frame>
    <description>Compare study treatments for primary outcomes post-treatment with the PROMIS 5 item Anger scale.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anger</measure>
    <time_frame>2 months</time_frame>
    <description>Compare study treatments for primary outcomes post-treatment with the PROMIS 5 item Anger scale.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anger</measure>
    <time_frame>3 months</time_frame>
    <description>Compare study treatments for primary outcomes post-treatment with the PROMIS 5 item Anger scale.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anger</measure>
    <time_frame>6 months</time_frame>
    <description>Compare study treatments for primary outcomes post-treatment with the PROMIS 5 item Anger scale.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Exploratory Outcome Health Service Utilization</measure>
    <time_frame>6 months</time_frame>
    <description>We will utilize EMR and database records to compare treatment groups for healthcare utilization (e.g., medical visits) during final 3 months of the study vs. 3 months prior to enrollment.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1200</enrollment>
  <condition>Pain, Chronic</condition>
  <arm_group>
    <arm_group_label>Empowered Relief</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A certified instructor delivers 1 session of pain relief skills intervention (Empowered Relief) to groups of patients who were randomized to this treatment arm.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Online 8-session Cognitive Behavioral Therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A trained psychologist delivers 8 sessions of low-literacy CBT (the LAMP protocol) to groups of patients who were randomized to this treatment arm.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Education</intervention_name>
    <description>Participants will receive one of two educational programs.</description>
    <arm_group_label>Empowered Relief</arm_group_label>
    <arm_group_label>Online 8-session Cognitive Behavioral Therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. At least 18 years of age or older of either sex (and all genders).&#xD;
&#xD;
          2. Chronic pain (pain that occurs on at least half of the days of 3 months or more).&#xD;
&#xD;
          3. Past-month average pain intensity score of at least 3/10.&#xD;
&#xD;
          4. Ability to adhere to and complete study protocols.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Inability to provide informed consent.&#xD;
&#xD;
          2. Cognitive impairment, non-English speaking, or psychological factors that would&#xD;
             preclude comprehension of material and/or full participation in the study including&#xD;
             group treatment.&#xD;
&#xD;
          3. Active suicidality at screening.&#xD;
&#xD;
          4. Study staff may exclude individuals with a known history of disruptive behavior to&#xD;
             minimize contamination of the learning environment for an entire treatment cohort.&#xD;
&#xD;
          5. Receipt of either study treatment in the past 3 months.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Emma A Adair, BS</last_name>
    <phone>6097448937</phone>
    <email>eadair@stanford.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Corinne Jung, PhD</last_name>
    <phone>(650) 724-0522</phone>
    <email>Cejung@stanford.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Phoenix VA Health Care System</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85012</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Toyia Dillion</last_name>
      <phone>602-277-5551</phone>
      <phone_ext>2442</phone_ext>
      <email>toyia.dillon@va.gov</email>
    </contact>
    <investigator>
      <last_name>Aram Mardian, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Eric Hanson, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>SCAN Health Plan</name>
      <address>
        <city>Long Beach</city>
        <state>California</state>
        <zip>90806</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gabby Riazi, MPH</last_name>
      <phone>562-308-5880</phone>
      <phone_ext>5880</phone_ext>
      <email>g.riazi@scanhealthplan.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Humana</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Arayam Hailu, BS</last_name>
      <phone>650-887-4497</phone>
      <email>arayamyh@stanford.edu</email>
    </contact>
    <investigator>
      <last_name>Stephen Stemkowski, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jackie Miefert, MS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lehigh Valley Health Network</name>
      <address>
        <city>Allentown</city>
        <state>Pennsylvania</state>
        <zip>18103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elizabeth Heggan, BS</last_name>
      <email>elizabeth_a.heggan@lvhn.org</email>
    </contact>
    <investigator>
      <last_name>Steve Denton, LCSW</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Intermountain Healthcare</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne Haroldsen</last_name>
    </contact>
    <investigator>
      <last_name>Joel Porter, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2023</verification_date>
  <study_first_submitted>August 5, 2022</study_first_submitted>
  <study_first_submitted_qc>November 4, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 10, 2022</study_first_posted>
  <last_update_submitted>April 21, 2023</last_update_submitted>
  <last_update_submitted_qc>April 21, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">April 24, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Stanford University</investigator_affiliation>
    <investigator_full_name>Beth Darnall</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chronic Pain</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

